logo
  

Brink's Backs FY21 Adj. EPS Outlook, Trims Revenue Guidance - Quick Facts

While reporting financial results for the second quarter on Thursday, The Brink's Co. (BCO) maintained its adjusted earnings guidance for the full-year 2021, while trimming annual revenue outlook.

For fiscal 2021, the company now projects earnings from continuing operations in a range of $2.20 to $2.35 per share and adjusted earnings from continuing operations in a range of $4.35 to $5.55 per share on revenues between $4.20 billion and $4.60 billion.

Previously, the company expected earnings from continuing operations in a range of $2.55 to $2.65 per share and adjusted earnings from continuing operations in a range of $4.35 to $5.55 per share on revenues between $4.25 billion and $4.65 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.02 per share on revenues of $4.41 billion for the year. Analysts' estimates typically exclude special items.

"We expect continued revenue recovery in the second half to provide a strong jumping off point for 2022, when our full-year revenue is expected to exceed comparable 2019 pre-Covid revenue levels," said Doug Pertz, president and chief executive officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
RELATED NEWS
Follow RTT